484068-07-7

Upstream product

• 484068-06-6 (R)-2-(4-Methoxy-benzyloxy)-2-phenethyl-pentan-1-ol 
• 484068-05-5 2-(4-methoxybenzyloxy)-4-phenyl-2-propylbut-3-en-1-ol 
• 484068-04-4 2-(4-methoxybenzyloxy)-2-propylbut-3-en-1-ol 
• 484068-03-3 2-propyl-2-vinyl-oxirane 
• 19265-24-8 1-chloropentane-2-one 
• 591-50-4 iodobenzene 
• 19493-09-5 Methylenetriphenylphosphorane 

Downstream Products

• 484068-14-6 (R)-5-(4-Methoxy-benzyloxy)-2-[(S)-1-(3-nitro-phenyl)-allyl]-3-oxo-5-phenethyl-octanoic acid methyl ester 
• 484068-15-7 (R)-5-Hydroxy-2-[(S)-1-(3-nitro-phenyl)-allyl]-3-oxo-5-phenethyl-octanoic acid methyl ester 
• 484068-16-8 (R)-4-Hydroxy-3-[(R)-1-(3-nitro-phenyl)-allyl]-6-phenethyl-6-propyl-5,6-dihydro-pyran-2-one 
• 484068-08-8 3-(4-methoxybenzyloxy)-3-phenylethylhexan-1-al 

Relevant academic research and scientific papers

Utilization of molybdenum- and palladium-catayzed dynamic kinetic asymmetric transformations for the preparation of tertiary and quaternary stereogenic centers: A concise synthesis of Tipranavir

Tipranavir, an important antiviral agent in clinical development for the treatment of HIV, is synthesized in 15 linear steps from readily available starting materials in 25% overall yield by utilizing Pd- and Mo-catalyzed DYKAT reactions to control the qu